ScholarIQanswers from OpenAlex & ORCID
Paul F. Schellhammer
ResearcherPublications, citations & collaboration network
Paul F. Schellhammer is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Paul F. Schellhammer have?
ScholarIQindexed works
Paul F. Schellhammer has 377 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Paul F. Schellhammer have?
ScholarIQcitation count
Paul F. Schellhammer has 24,728 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Paul F. Schellhammer?
ScholarIQh-index
Paul F. Schellhammer has an h-index of 64 in OpenAlex.
What is the i10-index of Paul F. Schellhammer?
ScholarIQi10-index
Paul F. Schellhammer has an i10-index of 195 in OpenAlex.
What is the OpenAlex record for Paul F. Schellhammer?
ScholarIQopenalex
The OpenAlex for Paul F. Schellhammer is on the source record.
What are the most-cited papers on Paul F. Schellhammer?
ScholarIQmost cited works
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach, Gerald E. Hanks, Howard D. Thames, Paul F. Schellhammer, William U. Shipley, Gerald H. Sokol, Howard M. Sandler
Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
Maha Hussain, Catherine M. Tangen, Donna L. Berry, Celestia S. Higano, E. David Crawford, Glenn Liu, George Wilding, Stephen M. Prescott, S.K. Sundaram, Eric J. Small, Nancy A. Dawson, Bryan Donnelly, Peter Venner, Ulka N. Vaishampayan, Paul F. Schellhammer, David I. Quinn, Derek Raghavan, Benjamin Ely, Carol M. Moinpour, Nicholas J. Vogelzang, Ian M. Thompson
Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.
Michael F. Sarosdy, Paul F. Schellhammer, Gary Bokinsky, Paul R. Kahn, Roberto Chao, Lawrence Yore, Joseph Zadra, Daniel Burzon, Gerald Osher, Julia A. Bridge, Steven M. Anderson, Sonny L. Johansson, Michael M. Lieber, Mark S. Soloway, Kerry Flom
SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
Claus G. Roehrborn, John D. McConnell, JAIME BONILLA, Sidney Rosenblatt, Perry B. Hudson, GHOLEM H. MALEK, Paul F. Schellhammer, Reginald C. Bruskewitz, Alvin M. Matsumoto, Lloyd H. Harrison, Harold A. Fuselier, Patrick Walsh, Johnny Roy, Gerald L. Andriole, Martin Resnick, Joanne Waldstreicher, for the PROSCAR LONG-TERM EFFICACY AND SAFETY STUDY
Clinical Evaluation of a Multi-target Fluorescent in Situ Hybridization Assay for Detection of Bladder Cancer
Michael F. Sarosdy, Paul F. Schellhammer, Gary Bokinsky, Paul R. Kahn, Roberto Chao, Lawrence Yore, Joseph Zadra, Daniel Burzon, Gerald Osher, Julia A. Bridge, Steven M. Anderson, Sonny L. Johansson, Michael M. Lieber, Mark S. Soloway, Kerry Flom